TABLE 2 Characteristics of the action of non-insulin hypoglycaemic drugs
Lu P, Takai K, Weaver VM, Werb Z
Some drugs for the treatment of T2DM may cause systemic side-effects such as hypoglycemia, and the long-term administration of insulin could promote brain insulin resistance (17)
In 2022, Eli Lilly introduced Mounjaro (tirzepatide), a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, as a direct competitor of Ozempic
Alternatives to an intramuscular injection are: Oral Vitamin B12 at a dose of at least 1000mcg per day
Vandematram Arcade, New Chandlodia, Ahemdabad, 382481 Vendor Details Country of origin: India 889 MRP 1778.7750% off Save more with additional offers Flat Rs.150 on a Min Transaction of Rs.1000